624 related articles for article (PubMed ID: 33342895)
1. A Case of Pregabalin-Induced Parkinsonism.
Ari BC; Domac FM; Kenangil GO
Neurol India; 2020; 68(6):1469-1471. PubMed ID: 33342895
[TBL] [Abstract][Full Text] [Related]
2. [Pregabalin-induced parkinsonism: A case report].
Masmoudi I; Gras-Champel V; Barbieux-Vaquez D; Masmoudi K
Therapie; 2017 Jun; 72(3):395-396. PubMed ID: 27817842
[No Abstract] [Full Text] [Related]
3. Aripiprazole-induced Parkinsonism with pregabalin as a confounder.
Kaur U; Ojha B; Pathak BK; Singh A; Gambhir IS; Chakrabarti SS
Acta Neurol Belg; 2021 Oct; 121(5):1351-1356. PubMed ID: 32444941
[No Abstract] [Full Text] [Related]
4. Parkinsonism associated with gabapentinoid drugs: A pharmacoepidemiologic study.
Pacheco-Paez T; Montastruc F; Rousseau V; Chebane L; Lapeyre-Mestre M; Renoux C; Montastruc JL
Mov Disord; 2020 Jan; 35(1):176-180. PubMed ID: 31633228
[TBL] [Abstract][Full Text] [Related]
5. Pregabalin-induced parkinsonism: a case report.
Perez Lloret S; Amaya M; Merello M
Clin Neuropharmacol; 2009; 32(6):353-4. PubMed ID: 19952879
[TBL] [Abstract][Full Text] [Related]
6. Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.
Morley JF; Pawlowski SM; Kesari A; Maina I; Pantelyat A; Duda JE
Parkinsonism Relat Disord; 2014 Jul; 20(7):738-42. PubMed ID: 24742370
[TBL] [Abstract][Full Text] [Related]
7. Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety.
Owen RT
Drugs Today (Barc); 2007 Sep; 43(9):601-10. PubMed ID: 17940637
[TBL] [Abstract][Full Text] [Related]
8. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
Rev Neurol (Paris); 1994 Nov; 150(11):757-62. PubMed ID: 7597368
[TBL] [Abstract][Full Text] [Related]
9. Differentiating Parkinson's disease from drug-induced Parkinsonism.
Wearne D; McCarthy M; Orr C
Aust N Z J Psychiatry; 2019 Sep; 53(9):923-924. PubMed ID: 30897918
[No Abstract] [Full Text] [Related]
10. Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.
Munhoz RP; Bertucci Filho D; Teive HA
Neurol Sci; 2017 Feb; 38(2):319-324. PubMed ID: 27853909
[TBL] [Abstract][Full Text] [Related]
11. DAT-SPECT imaging in cases of drug-induced parkinsonism in a specialty movement disorders practice.
Yomtoob J; Koloms K; Bega D
Parkinsonism Relat Disord; 2018 Aug; 53():37-41. PubMed ID: 29748111
[TBL] [Abstract][Full Text] [Related]
12. Asymmetry in clinical features of drug-induced parkinsonism.
Sethi KD; Zamrini EY
J Neuropsychiatry Clin Neurosci; 1990; 2(1):64-6. PubMed ID: 1983774
[TBL] [Abstract][Full Text] [Related]
13. Improvement in drug-induced parkinsonism with electroconvulsive therapy.
Baez MA; Avery J
Am J Geriatr Pharmacother; 2011 Jun; 9(3):190-3. PubMed ID: 21565562
[TBL] [Abstract][Full Text] [Related]
14. Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson's disease?
Lim TT; Ahmed A; Itin I; Gostkowski M; Rudolph J; Cooper S; Fernandez HH
Int J Neurosci; 2013 Mar; 123(3):170-4. PubMed ID: 23078283
[TBL] [Abstract][Full Text] [Related]
15. [¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis.
Brigo F; Matinella A; Erro R; Tinazzi M
Eur J Neurol; 2014 Nov; 21(11):1369-e90. PubMed ID: 24779862
[TBL] [Abstract][Full Text] [Related]
16. Manganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable Features.
Kwakye GF; Paoliello MM; Mukhopadhyay S; Bowman AB; Aschner M
Int J Environ Res Public Health; 2015 Jul; 12(7):7519-40. PubMed ID: 26154659
[TBL] [Abstract][Full Text] [Related]
17. Drug induced parkinsonism: a common cause of parkinsonism in older people.
Thanvi B; Treadwell S
Postgrad Med J; 2009 Jun; 85(1004):322-6. PubMed ID: 19528308
[TBL] [Abstract][Full Text] [Related]
18. Psychiatric Patients on Neuroleptics: Evaluation of Parkinsonism and Quantified Assessment of Gait.
Yahalom H; Israeli-Korn S; Linder M; Yekutieli Z; Karlinsky KT; Rubel Y; Livneh V; Fay-Karmon T; Hassin-Baer S; Yahalom G
Clin Neuropharmacol; 2020; 43(1):1-6. PubMed ID: 31815747
[TBL] [Abstract][Full Text] [Related]
19. Incidence and time trends of drug-induced parkinsonism: A 30-year population-based study.
Savica R; Grossardt BR; Bower JH; Ahlskog JE; Mielke MM; Rocca WA
Mov Disord; 2017 Feb; 32(2):227-234. PubMed ID: 27779780
[TBL] [Abstract][Full Text] [Related]
20. Parkinsonism in a nursing home: underrecognition.
Friedman JH; Fernandez HH; Trieschmann MM
J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):39-41. PubMed ID: 15018697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
